Palisade Bio Inc expected to post a loss of $2.43 a share - Earnings Preview

Palisade Bio

14/03/2023 12:47

* Palisade Bio Inc  PALI.OQ   PALI.O  is expected to show no
change in quarterly revenue when it reports  results on March 16
(estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Palisade Bio Inc is
for a
loss of $2.43 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Palisade
Bio Inc
is $25​, above​ its last closing price of $2.13. ​​​

This summary was machine generated March 14 at 12:47 GMT.  All
figures in US dollars  unless otherwise stated